Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Risvan® (risperidone) – New drug approval

April 2, 2024 - Rovi announced the FDA approval of Risvan (risperidone), for the treatment of schizophrenia in adults.

Download PDF

Rx navigation